References
- Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood 1994; 84: 2854–67.
- Myones BL, McCurdy D. The antiphospholipid syndrome: Immunologic and clinical aspects. Clinical spectrum and treatment. J Rheumatol 2000; 27 (Suppl 58): 20–8.
- Yamazaki M, Asakura H, Kawamura Y, Ohka T, Endo M, Matsuda T. Transient lupus anticoagulant induced by EpsteinBarr virus infection. Blood Coagul Fibrinolysis 1991; 2: 771–4.
- Sorice M, Pittoni V, Griggi T, Losardo A, Leri O, Magno MS, et al. Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol 2000; 120 : 301–6.
- Brodeur GM, O’Neill PJ, Wilimas JA. Acquired inhibitors of coagulation in nonhemophiliac children. J Pediatr 1980; 96: 439–41.
- Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996; 128: 319–23.
- Male C, Lecbner K, Eicbinger S, Kyrle PA, Kapiotis S, Wank H, et al. Clinical significance of lupus anticoagulants in children. J Pediatr 1999; 134: 199–205.
- Sumaya CV, Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 1985; 75: 1011–9.
- Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185–90.
- Bectom DL, Stine KC. Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: The hemorrhagic lupus anticoagulant syndrome. J Pediatr 1997; 130: 998–1000.